Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started

US sues Rite Aid for missing opioid red flags

Stock Markets Mar 14, 2023 12:32PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
WMT
+0.82%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ABC
+3.63%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
RAD
-5.41%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Jonathan Stempel

WASHINGTON (Reuters) - The U.S. government on Monday sued Rite Aid (NYSE:RAD) Corp, accusing the pharmacy chain of missing "red flags" as it illegally filled hundreds of thousands of prescriptions for controlled substances, including opioids.

In a complaint filed in Cleveland federal court, the Department of Justice said Rite Aid repeatedly filled prescriptions from May 2014 to June 2019 that were medically unnecessary, for off-label use, or not issued in the usual course of professional practice.

"The Justice Department is using every tool at our disposal to confront the opioid epidemic that is killing Americans and shattering communities across the country," Attorney General Merrick Garland said in a statement.

Rite Aid pharmacists were accused of ignoring obvious signs of misuse, including in prescriptions for "trinities," a combination of opioids, benzodiazepine, and muscle relaxants preferred by drug abusers for their increased euphoric effect.

The Justice Department also said Rite Aid intentionally deleted some pharmacists' internal warnings about suspicious prescribers, such as "cash only pill mill???", while admonishing them to "be mindful of everything that is put in writing."

"These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid's stores," Associate Attorney General Vanita Gupta said.

Rite Aid is one of the country's largest pharmacy chains, with more than 2,330 stores in 17 U.S. states. It did not immediately respond to requests for comment.

The Justice Department accused Rite Aid of violating the federal False Claims Act by submitting false prescription claims to government healthcare programs such as Medicare and Medicaid.

It joined a whistleblower lawsuit filed in 2019 by two pharmacists and a pharmacy technician from Rite Aid stores in Pennsylvania, North Carolina and West Virginia.

The Justice Department occasionally joins whistleblower cases it considers stronger.

It has also sued Walmart (NYSE:WMT) Inc and drug distributor AmerisourceBergen (NYSE:ABC) Corp over their alleged roles in the nation's opioid crisis.

More than 500,000 people died from drug overdoses in the United States from 1999 to 2020, including more than 90,000 in 2020 alone, according to the U.S. Centers for Disease Control and Prevention.

The case is U.S. ex rel White et al v Rite Aid Corp et al, U.S. District Court, Northern District of Ohio, No. 21-01239.

US sues Rite Aid for missing opioid red flags
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (5)
Angel Nieto
Angel Nieto Mar 14, 2023 2:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How absurd! what exactly is the US government looking to get from a $160M cap company at this point? To bankrupt them?!? that will surely show RAD a lesson and in the process potentially force thousands of people to be unable to get any of their prescriptions filled due to a lack of pharmacies in their neighborhoods - sounds like a brilliant idea!
Mike Luber
Mike Luber Mar 13, 2023 11:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good thing the FDA and the dea didn't miss the red flags.....oh wait they did
Red Riley
Red Riley Mar 13, 2023 9:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
of course blame everyone but yourself
Outdoors with Alex
Outdoors with Alex Mar 13, 2023 8:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how does Walmart get affected by this 🤣
gab nea
gab nea Mar 13, 2023 5:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good for US!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email